Magellan Health Insights
  • Home
  • About
  • Resources
  • Voices
  • Contact

COVID-19 Vaccine and Drug Pipeline

by Maryam Tabatabai July 21, 2020COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has taken a substantial toll on human life, not to mention our way of life. With over 14 million confirmed global cases and the death toll approaching 612,000, it is one of the most significant crises in recent history. In the United States (US), the country with the most cases and deaths, confirmed cases exceed 3.8 million and over 141,000 deaths have been reported as a result of this outbreak. As cases surge in certain parts of the country and the world, safe and effective vaccines and therapies are crucial to combatting this virus.  

Given the torrent of information around the COVID-19, MRx Pipeline+ was developed to profile agents in development. Currently, there are no US Food and Drug Administration (FDA)-approved treatments or vaccines for SARS-CoV-2, the virus that causes COVID-19. Over 200 agents are being evaluated to treat the virus. These include new emerging molecular entities as well as approved drugs that are already available to treat other conditions and now being repurposed for COVID-19. According to the World Health Organization (WHO), 24 vaccine candidates have entered human trials and over 140 vaccine hopefuls are in preclinical evaluation.

Scientists around the world are working tirelessly to discover a vaccine for COVID-19. Vaccines candidates go through many stages of study. The average time to develop a vaccine ranges from 10 to 15 years. The Ebola vaccine, newly-minted in December 2019, only took about 6 years to be approved, whereas an HIV/AIDS vaccine has still not come to market after about 40 years. Given this pandemic’s magnitude, extraordinary measures from public and private stakeholders have been introduced to accelerate vaccine development.

COVID-19 has presented us with many challenges. Mitigation measures and safe and effective vaccines and treatments are key to restoring a new normalcy. MRx Pipeline+ captures relevant evidence on select drug and vaccine contenders to keep everyone well-sourced on the COVID-19 pipeline.

Share on FacebookShare on TwitterShare on Linkedin
Tags: Coronavirus, coronavirus pandemic, COVID-19, COVID-19 Vaccine, FAQ Coronavirus, pandemic, Vaccine, virus vaccine
Maryam Tabatabai
Maryam Tabatabai
Dr. Maryam Tabatabai is the senior director of drug information for Magellan Rx Management. She provides oversight and actively engages in evidence-based writing, development of clinical policies, new drug evaluations, as well as specialty and traditional drug pipeline forecasting. Dr. Tabatabai provides leadership and serves on a number of key committees and is the editor-in-chief for several Magellan Rx Management clinical publications, including MRx Pipeline, Clinical Alert, and Trend Alert blog. Since obtaining her Doctor of Pharmacy degree, she has gained meaningful pharmacy and clinical experience in the community, academic, hospital, and ambulatory care settings. Upon completing her pharmacy practice residency, she joined Magellan where she has been a central clinical resource across the enterprise
Previous post BIPOC Mental Health Awareness Q&A with Dr. Beall-Wilkins Next post Curious about Discount Cards? – 5 Things you should know!

Related Articles

Grief and Loss

Loss and Grief during the Pandemic

by Steven E. Pratt, MD
January 12, 2021
A full length photo of woman using laptop while holding documents at home. Young female is sitting on window sill. She is working from home.

Anxiety and COVID-19

by Caroline Carney, MD
March 18, 2020
MH blog photo 2_1024 x 683

The Role of Lived Experience in Suicide Prevention

by Tom Lane
September 8, 2020

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Magellan Health Logo

To learn more about how Magellan can support your organization, please visit MagellanHealth.com.

Topic suggestions or questions?
Send us your ideas at

Connect with us:

Trending Topics

  • A Present Day Look at PTSD
  • Medicine Cabinet Minefield: How old prescriptions drugs are fueling an opioid addiction crisis
  • The Trends and Complexities of Provider-Administered Drugs

Categories

Stay in the Know

Get the latest news and trending insights sent straight to your inbox.


HomeAboutResourcesVoicesContact
© 1999-2016 Magellan Health, Inc. All Rights Reserved.